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LETTERS TO THE EDITORRegarding “Limb-salvage angioplasty in vascular
surgery practice”
We read with great interest the article on infrainguinal angio-
plasty for limb salvage by Tefera et al.1 Although distal bypasses are
considered as the most durable revascularization procedures for
patients with chronic critical limb ischemia secondary to infrapop-
liteal occlusive disease,2 there is increasing evidence of usefulness of
endovascular techniques. We would like to make some necessary
comments regarding this study, which adds to the growing litera-
ture on infrapopliteal angioplasty.
1. There is frequently a multisegmental or multivessel in-
volvement (ie, two or three crural arteries) in these pa-
tients.3 Did the authors consider recanalization of one
patent vessel as a technical success, or was an attempt made
to open up more than one vessel in the leg?
2. Complications such as major dissection or plaque disrup-
tion with subsequent thrombosis may result in an acute
deterioration in the severity of ischemia, especially so if the
major collaterals are involved. As the “bail-out” option of
stent is not applicable to these vessels, what was the treat-
ment protocol for such events?
3. Was surgical revascularization needed on an emergent
basis? This would mandate a good surgical backup for
endovascular procedures.
4. We agree with the authors that ankle-brachial index mea-
surements may not be helpful in more than 50% of patients
during the follow-up period. What was their method of
evaluation in patients with non-compressible leg vessels?
We remain enthusiastic about this procedure and, like others,4,5
consider infrapopliteal angioplasty to be the initial choice for
management of critical limb ischemia. We are a group of vascular
surgeons who realized the magnitude of endovascular options
more than 14 years ago and use subintimal angioplasty especially in
diabetic patients with significant comorbidities. Long-term pa-
tency rates may not be as high or comparable with surgical revas-
cularization, but if relief of rest pain wound healing and limb
salvage can be achieved by a nonsurgical, minimally invasive op-
tion, the procedure has a good future.
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Reply
We agree with Dr Parakh in that percutaneous infrainguinal
revascularization is an important adjunct and that there is growing
evidence about its usefulness in a selected group of patients. Short
of good prospective studies, however, some important questions
(such as durability) may not be easily answered. Dr Parakh raises
some important questions.
1. We attempted to revascularize more than one crural vessel.
Unfortunately, we could not make conclusive statements be-
cause some of our data were incomplete; however, recanalizing
one vessel was considered a technical success. The question
remains whether revascularizing more than one vessel can have
better clinical success.
2. We had only one case in which thrombosis with clinical deteri-
oration occurred, and this patient was treated with an overnight
thrombolysis. As a bailout very recently (since the publication
of this article), we have used small coronary stent.
3. We are a group of vascular surgeons and do not need any
backup. Overall, complications requiring emergency operation
are rare. In our series, no case needed emergency revasculariza-
tion.
4. All patients are followed up clinically for resolution of symp-
toms such as rest pain, healing of wounds, or toe amputation
sites. Superficial femoral artery lesions can be followed up by
duplex ultrasonography. We are currently evaluating tissue
oxygen tension on the dorsum of the foot to quantify improve-
ments in oxygenation.
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Regarding “Lifeline registry of endovascular
aneurysm repair: Long-term primary
outcome measures”
I read with interest the results of long-term follow-up of
patients in the Lifeline Registry of endovascular aneurysm repair
(EVAR; J Vasc Surg 2005;42:1-10) and take issue with the au-
thors’ conclusion that EVAR is an effective and durable treatment
for infrarenal aortic aneurysms. This conclusion is based on a low
risk of aneurysm rupture and aneurysm-related death and a low
surgical conversion rate. However, most EVARs were performed
in patients with small aneurysms (1040 patients had aneurysms
5.5 cm in diameter), and it is known that open surgery does not
confer a survival advantage for at least 8 years when such patients
are compared with those assigned to aneurysm surveillance.1 Al-
though the natural history of small aneurysms remains uncertain,
reports of rupture incidence for aneurysms smaller than 5 cm range
from 0% at 5 years to 1% per year.2,3 Unlike open surgery, in which
the diseased vessel is replaced by a prosthetic graft, EVAR allows
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